CoQ10 and NAFLD

CO-Q10 Supplementation Improves Fatty Liver, Reduces Markers of Inflammation in NAFLD

A new randomized double blind trial of both men and women with NAFLD (Nonalcoholic fatty liver disease) found positive results for supplemental coenzyme Q10.  NAFLD describes a disease of the liver that is characterized by fat accumulation in the liver, enlargement of the liver and increased serum liver enzyme levels.  Increase inflammation also accompanies this…

Vitamin E

The Health Benefits of Vitamin E

Vitamin E, an antioxidant, is a fat-soluble nutrient and can only be obtained through food or through supplementation.  It is well known for its benefits for the skin, however it also beneficially for the heart and the brain.  A deficiency of Vitamin E is usually caused by a genetic abnormality or a fat malabsorption disorder.…

Glutamine and Fatty Liver Disease

Could Glutamine Protect Against Progression of Fatty Liver Disease?

A recent study published in the Journal of Nutrition supports oral supplementation with L-Glutamine to prevent the progression of non-alcoholic steatohepatitis (NASH).  NASH is the second state of non-alcoholic fatty liver disease (NAFLD) and is distinguished by changes due to inflammation that can progress the disease to fibrosis, cirrhosis and liver cancer. Mice were fed…

Fatty Liver Disease

Omega-3 May Help Fight Fatty Liver Disease

According to a new pilot study a high dose Omega-3 supplement may improve Non-Alcoholic Fatty Liver Disease (NAFLD) markers. This pre-specified sub study of the WELCOME Trial (Wessex Evaluation of Fatty Liver and Cardiovascular markers in NAFLD with Omacor Therapy), a double blinded randomized controlled trial, looked at 16 individuals with NAFLD.  These participants were…

liver

Curcumin Touted For Metabolic Benefits in People with Fatty Liver Disease

A new study suggests daily supplementation with Curcumin (Turmeric) might improve Body Mass Index (BMI), metabolic status and liver biomarkers in people with Non-Alcoholic Fatty Liver Disease (NAFLD). 87 people with grades 1-3 NAFLD (Non-Alcoholic Fatty Liver Disease) participated in this randomized controlled clinical study.  The study lasted 8 weeks.  Participants were assigned randomly to…